Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD

  • Roberto W. Dal Negro | robertodalnegro@gmail.com National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy.
  • Paola Turco Research and Clinical Governance, Verona, Italy.
  • Massimiliano Povero AdRes Health Economics and Outcome Research, Torino, Italy.

Abstract

Correction to: Multidiscip RespirMed (2019) 14:30 https://doi.org/10.1186/s40248-019-0192-5

After publication of the Original research article [1] it was brought to our attention that the sentence at the bottom of the section entitled Discussion (pag 6 of 9, just below Fig. 4) must be corrected as follows: “In real life, DPIs are highly prescribed in Italian COPD patients being their prescription usually independent of their known basic characteristics and technical differences, such as the different number of main actions required for their actuation (7 for Breezhaler, 4 for Turbohaler, and 3 for the remaining devices),” and their intrinsic resistance, ranging from 0.017 kPa0.5 L/min to 0.039 kPa0 .5 L/min [28, 29].

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2019-10-21
Info
Issue
Section
Correction
Keywords:
Dry powder inhalers, COPD, Global usability score, Inhalation therapy, Usability
Statistics
  • Abstract views: 550

  • PDF: 85
  • HTML: 17
How to Cite
Dal Negro, R. W., Turco, P., & Povero, M. (2019). Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD. Multidisciplinary Respiratory Medicine, 14(1). https://doi.org/10.4081/mrm.2019.65

Most read articles by the same author(s)